In order to validate the correlation between CHD1L and drug resistance in NSCLC cells, we constructed cisplatin-resistant A549 and PC9 cell lines that displayed distinctive epithelial morphology. This evidence concerns the gene CHD1L and non-small cell lung carcinoma.